Cost-Effectiveness in Health and Medicine (2nd Revised edition)

ISBN : 9780190492939

Peter J. Neumann; Louise B. Russell; Joanna E. Siegel; Theodore G. Ganiats; Gillian D. Sanders
536 ページ
156 x 235 mm

A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT "At last, a manual of operations for comparing the cost-effectiveness of a preventive service with a treatment intervention." -American Journal of Preventive Medicine Twenty years after the first edition of COST-EFFECTIVENESS IN HEALTH AND MEDICINE established the practical benchmark for cost-effectiveness analysis, this completely revised edition of the classic text provides an essential resource to a new generation of practitioners, students, researchers, and policymakers. Produced by the Second Panel on Cost-Effectiveness in Health and Medicine-a team of 13 experts from fields including decision science, economics, ethics, psychology, and medicine-this new edition is a comprehensive guide to the use of cost-effectiveness analysis as an evaluative tool at the institutional and policy levels. As health care systems face increasing pressure to derive maximum value from expenditures, the guidelines in this new text represent not just the best information available, but a vital guide to health care decision-making in a challenging new era. Completely revised and enriched with examples and expanded coverage, this second edition of COST-EFFECTIVENESS IN HEALTH AND MEDICINE builds on its predecessor's excellence, offering required reading for both analysts and decision makers.


Second Panel on Cost-Effectiveness in Health and Medicine
First Panel on Cost-Effectiveness in Health and Medicine
1. Using Cost-Effectiveness Analysis in Health and Medicine: Experiences since the Original Panel
2. Theoretical Foundations of Cost-Effectiveness Analysis in Health and Medicine
3. Recommendations on Perspectives for the Reference Case
4. Designing a Cost-Effectiveness Analysis
5. Decision Models in Cost-Effectiveness Analysis
6. Identifying and Quantifying the Consequences of Interventions
7. Valuing Health Outcomes
8. Estimating Costs and Valuations of Non-Health Benefits in Cost-Effectiveness Analysis
9. Evidence Synthesis for Informing Cost-Effectiveness Analysis
10. Discounting in Cost-Effectiveness Analysis
11. Reflecting Uncertainty in Cost-Effectiveness Analysis
12. Ethical and Distributive Considerations
13. Reporting Cost-effectiveness Analyses
Appendix: Summary of Recommendations by Chapter
Worked Examples
Overview of Worked Examples
Worked Example 1: The Cost-Effectiveness of Treatment for Individuals with Alcohol Use Disorders: A Reference Case Analysis
Worked Example 2: The Cost-Effectiveness of Home Palliative Care for Patients at the End of Life


Peter J. Neumann is Director of the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, and Professor of Medicine at Tufts University School of Medicine.; Gillian D. Sanders is Director of the Duke Evidence Synthesis Group at the Duke Clinical Research Institute, and Professor of Medicine at Duke University.; Louise B. Russell is Distinguished Professor, Institute for Health and Department of Economics, at Rutgers University.; Joanna E. Siegel is Director of Dissemination and Implementation at Patient-Centered Outcomes Research Institute (PCORI), Washington, DC.; Theodore G. Ganiats is Professor Emeritus, Health Services Research Center and Department of Family Medicine and Public Health, at University of California, San Diego.